Controlled trial of dipyridamole in cerebral vascular disease


Phase N/A Results


After the first evaluation, 8 treated patients and 6 control patients had died. At the second evaluation, 5 treated patients and 3 control patients had died. These differences were not statistically significant when patients in each treatment group were analyzed by diagnostic category.